Enlargement of the left atrium is associated with increased infiltration of immune cells in patients with atrial fibrillation who had undergone surgery

[1]  T. Chao,et al.  Clinical Outcome of Catheter Ablation in Patients With Nonparoxysmal Atrial Fibrillation: Results of 3-Year Follow-Up , 2012, Circulation. Arrhythmia and electrophysiology.

[2]  Yawei Xu,et al.  Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation: a systematic review and meta-analysis of observational studies. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  T. Chao,et al.  Associations between renal function, atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[4]  Y. Koyama,et al.  A pre-existent elevated C-reactive protein is associated with the recurrence of atrial tachyarrhythmias after catheter ablation in patients with atrial fibrillation. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[5]  Y. Iwasaki,et al.  Recruitment of immune cells across atrial endocardium in human atrial fibrillation. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[6]  Mien-Cheng Chen,et al.  Increased inflammatory cell infiltration in the atrial myocardium of patients with atrial fibrillation. , 2008, The American journal of cardiology.

[7]  T. Uejima,et al.  Prevalence and prognosis of patients with atrial fibrillation in Japan: a prospective cohort of Shinken Database 2004. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[8]  S. Nattel,et al.  Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[9]  Å. Sjöholm,et al.  Endothelial inflammation in insulin resistance , 2005, The Lancet.

[10]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[11]  G. Lip,et al.  Endothelial dysfunction: methods of assessment and application to hypertension. , 2004, Current pharmaceutical design.

[12]  Peter Libby,et al.  Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis , 2002, Circulation research.

[13]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[14]  D. Levy,et al.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.

[15]  P. Wolf,et al.  Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. , 1985, JAMA.